ARCHIVES

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

Community Centers Group Lines Up A Speaker

January 10, 1975

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014